Advanced

Effect of two novel CGRP-binding compounds in a closed cranial window rat model

Juhl, Louise; Edvinsson, Lars LU ; Olesen, Jes and Jansen-Olesen, Inger (2007) In European Journal of Pharmacology 567(1-2). p.117-124
Abstract
We investigated the in vivo effects of two novel calcitonin gene-related peptide (CGRP) binding molecules in the genuine closed cranial window model in the rat. The RNA-Spiegelmer (NOX-C89) and the monoclonal CGRP antibody are CGRP scavengers and might be used as an alternative to CGRP-receptor antagonists in the treatment of migraine. Rats were anaesthetized and a closed cranial window established. Changes in dural and pial artery diameter and mean arterial blood pressure were measured simultaneously. Infusion of the RNA-Spiegelmer or the CGRP antibody alone had no effect on the arteries or the mean arterial blood pressure. We then used a bolus of 0.3 mu g/kg CGRP (n=6) or electrical stimulation (25 V, 5 Hz, 1 ms pulse width and of 10 s... (More)
We investigated the in vivo effects of two novel calcitonin gene-related peptide (CGRP) binding molecules in the genuine closed cranial window model in the rat. The RNA-Spiegelmer (NOX-C89) and the monoclonal CGRP antibody are CGRP scavengers and might be used as an alternative to CGRP-receptor antagonists in the treatment of migraine. Rats were anaesthetized and a closed cranial window established. Changes in dural and pial artery diameter and mean arterial blood pressure were measured simultaneously. Infusion of the RNA-Spiegelmer or the CGRP antibody alone had no effect on the arteries or the mean arterial blood pressure. We then used a bolus of 0.3 mu g/kg CGRP (n=6) or electrical stimulation (25 V, 5 Hz, 1 ms pulse width and of 10 s of duration) (n=6) to induce dilatation of dural and pial arteries (mediated via CGRP-receptors). Pre-treatment with the RNA-Spiegelmer inhibited CGRP-induced vasodilatation of the dural artery (from 38 +/- 17% to 7 +/- 3%) and the pial artery (from 14 +/- 1% to 3 +/- 2%) (P < 0.05). The RNA-Spiegelmer, however, did not significantly inhibit dilatation induced by electrical stimulation (P > 0.05). The CGRP antibody caused a significant reduction of the dural artery diameter caused by intravenous CGRP-in fusion (from 23 +/- 5% to 12 +/- 3%) (P < 0.05), but did not inhibit dilatation caused by electrical stimulation (P > 0.05). In conclusion, the CGRP scavengers effectively inhibited the effect of circulating CGRP but do not modify the effect of electdcal stimulation and the consequent liberation of CGRP from perivascular sensory nerve fibres. (c) 2007 Elsevier B.V. All rights reserved. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
meningeal artery, middle, middle cerebral artery, electrical stimulation, migraine, CGRP, CGRP antibody, RNA-Spiegelmer
in
European Journal of Pharmacology
volume
567
issue
1-2
pages
117 - 124
publisher
Elsevier
external identifiers
  • wos:000247281700016
  • scopus:34249075410
ISSN
1879-0712
DOI
10.1016/j.ejphar.2007.04.004
language
English
LU publication?
yes
id
91d278ae-ca43-45dd-a9b1-46de7014082c (old id 648472)
date added to LUP
2007-12-13 14:30:17
date last changed
2017-10-22 03:55:54
@article{91d278ae-ca43-45dd-a9b1-46de7014082c,
  abstract     = {We investigated the in vivo effects of two novel calcitonin gene-related peptide (CGRP) binding molecules in the genuine closed cranial window model in the rat. The RNA-Spiegelmer (NOX-C89) and the monoclonal CGRP antibody are CGRP scavengers and might be used as an alternative to CGRP-receptor antagonists in the treatment of migraine. Rats were anaesthetized and a closed cranial window established. Changes in dural and pial artery diameter and mean arterial blood pressure were measured simultaneously. Infusion of the RNA-Spiegelmer or the CGRP antibody alone had no effect on the arteries or the mean arterial blood pressure. We then used a bolus of 0.3 mu g/kg CGRP (n=6) or electrical stimulation (25 V, 5 Hz, 1 ms pulse width and of 10 s of duration) (n=6) to induce dilatation of dural and pial arteries (mediated via CGRP-receptors). Pre-treatment with the RNA-Spiegelmer inhibited CGRP-induced vasodilatation of the dural artery (from 38 +/- 17% to 7 +/- 3%) and the pial artery (from 14 +/- 1% to 3 +/- 2%) (P &lt; 0.05). The RNA-Spiegelmer, however, did not significantly inhibit dilatation induced by electrical stimulation (P &gt; 0.05). The CGRP antibody caused a significant reduction of the dural artery diameter caused by intravenous CGRP-in fusion (from 23 +/- 5% to 12 +/- 3%) (P &lt; 0.05), but did not inhibit dilatation caused by electrical stimulation (P &gt; 0.05). In conclusion, the CGRP scavengers effectively inhibited the effect of circulating CGRP but do not modify the effect of electdcal stimulation and the consequent liberation of CGRP from perivascular sensory nerve fibres. (c) 2007 Elsevier B.V. All rights reserved.},
  author       = {Juhl, Louise and Edvinsson, Lars and Olesen, Jes and Jansen-Olesen, Inger},
  issn         = {1879-0712},
  keyword      = {meningeal artery,middle,middle cerebral artery,electrical stimulation,migraine,CGRP,CGRP antibody,RNA-Spiegelmer},
  language     = {eng},
  number       = {1-2},
  pages        = {117--124},
  publisher    = {Elsevier},
  series       = {European Journal of Pharmacology},
  title        = {Effect of two novel CGRP-binding compounds in a closed cranial window rat model},
  url          = {http://dx.doi.org/10.1016/j.ejphar.2007.04.004},
  volume       = {567},
  year         = {2007},
}